Express Scripts Holding Company Profile (NASDAQ:ESRX)

Analyst Ratings

Consensus Ratings for Express Scripts Holding (NASDAQ:ESRX) (?)
Ratings Breakdown: 3 Sell Rating(s), 10 Hold Rating(s), 9 Buy Rating(s)
Consensus Rating:Hold (Score: 2.27)
Consensus Price Target: $81.42 (7.03% upside)

Analysts' Ratings History for Express Scripts Holding (NASDAQ:ESRX)
Show:
DateFirmActionRatingPrice TargetActions
7/27/2016Barclays PLCBoost Price TargetOverweight$85.00 -> $87.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/26/2016Jefferies GroupLower Price TargetBuy$98.00 -> $88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016Credit Suisse Group AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2016Morgan StanleyDowngradeEqual Weight -> Underweight$67.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2016Sanford C. BernsteinInitiated CoverageUnderperform$68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016Cowen and CompanyReiterated RatingPositive$83.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016Bank of America Corp.Reiterated RatingNeutral$82.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016WedbushReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/24/2016Citigroup Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Leerink SwannReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016FBR & CoLower Price TargetMkt Perform$90.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2016ArgusReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016Deutsche Bank AGReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2016Oppenheimer Holdings Inc.Reiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2016Evercore ISILower Price Target$74.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2016William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016MizuhoDowngradeBuy -> Neutral$93.00 -> $77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2016Goldman Sachs Group Inc.Lower Price TargetNeutral$82.00 -> $74.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2016Maxim GroupReiterated RatingBuy$109.00 -> $95.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2016Robert W. BairdLower Price TargetNeutral$85.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/23/2015BMO Capital MarketsBoost Price TargetMarket Perform$94.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/29/2015JPMorgan Chase & Co.Reiterated RatingBuy$105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2015Royal Bank Of CanadaBoost Price TargetOutperform$87.00 -> $96.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015StephensInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Express Scripts Holding (NASDAQ:ESRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/25/2016        
7/25/2016Q216$1.57$1.57$25.42 billion$25.20 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2016Q1$1.22$1.22$25.20 billion$24.80 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/16/2016Q4$1.56$1.56$26.58 billion$26.18 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q315$1.44$1.45$26.38 million$25.22 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2015Q215$1.40$1.44$26.13 billion$25.45 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2015Q115$1.10$1.10$24.34 billion$24.90 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2015Q414$1.38$1.39$25.68 billion$26.31 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2014Q314$1.29$1.29$24.93 billion$25.78 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q214$1.22$1.23$24.42 billion$25.11 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2014Q114$1.01$0.99$23.81 billion$23.69 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/20/2014Q413$1.12$1.12$25.49 billion$25.78 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2013Q313$1.08$1.08$25.01 billion$25.92 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2013Q2 2013$1.10$1.12$25.51 billion$26.40 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2013Q1 2013$0.97$0.99$25.55 billion$26.06 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/18/2013Q4 2012$1.04$1.05$27.24 billion$27.41 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2012Q312$0.99$1.02$27.48 billion$27.00 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012$0.82$0.88ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/10/2012$0.77$0.73ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2012$0.85$0.82ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2011$0.77$0.79ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/21/2011$0.69$0.71ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2011$0.69$0.66ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/16/2011$0.70$0.71ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Express Scripts Holding (NASDAQ:ESRX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 201613$1.20$1.36$1.24
Q2 201610$1.52$1.59$1.55
Q3 20166$1.74$1.74$1.74
Q4 20169$1.70$1.88$1.81
Q1 20172$1.35$1.38$1.37
Q2 20172$1.67$1.71$1.69
Q3 20172$1.82$1.85$1.84
Q4 20172$1.92$2.02$1.97
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Express Scripts Holding (NASDAQ:ESRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Express Scripts Holding (NASDAQ:ESRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/10/2016Everett NevilleVPSell800$74.11$59,288.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2016Mahon Thomas P MacDirectorSell5,482$73.93$405,284.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016Christopher A McginnisVPSell579$68.56$39,696.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Phyllis S AndersonVPSell614$71.14$43,679.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Everett NevilleVPSell4,323$71.00$306,933.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2015Gary WimberlyVPSell1,644$87.14$143,258.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Gary WimberlyVPSell46,069$86.15$3,968,844.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Glen D StettinVPSell2,674$84.39$225,658.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2015Glen D StettinVPSell27,603$87.55$2,416,642.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2014Keith J EblingVPSell10,000$84.25$842,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Steven B MillerVPSell4,896$83.57$409,158.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/28/2014Glen D StettinVPSell10,800$82.96$895,968.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2014John O ParkerDirectorSell25,822$78.75$2,033,482.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2014Maura C BreenDirectorSell13,128$77.80$1,021,358.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2014Edward B IgnaczakEVPSell9,886$75.28$744,218.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2014Seymour SternbergDirectorSell15,508$74.12$1,149,452.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2014Keith J EblingVPSell10,000$75.50$755,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2014Gary G BenanavDirectorSell12,694$70.82$898,989.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2014Sara E WadeVPSell20,000$70.44$1,408,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014David A NortonVPSell1,276$71.02$90,621.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Maura C BreenDirectorSell12,694$69.94$887,818.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2014George PazCEOSell681,508$71.21$48,530,184.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2014Keith EblingVPSell25,721$78.69$2,023,985.49View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2014Patrick McnameeCOOSell68,425$78.28$5,356,309.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2014Steven MillerVPSell12,664$77.96$987,285.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2014Keith EblingVPSell295,367$77.29$22,828,915.43View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2014Nicholas LahowchicDirectorSell7,650$72.00$550,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/26/2013Nicholas LahowchicDirectorSell12,694$70.00$888,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2013Mahon Thomas MacDirectorSell10,251$63.20$647,863.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013Maura C BreenDirectorSell10,527$64.12$674,991.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2013Woodrow Myers, Jr.DirectorSell7,128$64.66$460,896.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/19/2013Nicholas LahowchicDirectorSell20,377$66.26$1,350,180.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2013Woodrow A Myers JrDirectorSell1,750$62.57$109,497.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Woodrow A Myers JrDirectorSell2,000$63.75$127,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2013Jeffrey HallCFOSell13,307$61.13$813,456.91View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2013Woodrow A Myers JrDirectorSell13,462$61.22$824,143.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2013Keith J EblingEVPSell59,494$59.58$3,544,652.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/30/2013Patrick McnameeCOOSell271,972$59.65$16,223,129.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2013Mahon Thomas P MacDirectorBuy5,000$59.58$297,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2012Jeffrey HallCFOSell75,000$62.81$4,710,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2012Edward B IgnaczakEVPSell115,466$59.33$6,850,597.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Express Scripts Holding (NASDAQ:ESRX)
DateHeadline
07/30/16 05:55 AMHow has Express Scripts Holding Company:(NASDAQ:ESRX ... - The Daily Leicester
07/29/16 12:04 PMEXPRESS SCRIPTS HOLDING CO. Financials -
07/29/16 05:09 AMEXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
07/28/16 08:23 PMExpress Scripts Holding Company: Express Scripts Announces Final Results of Maximum Tender Offers
07/28/16 02:37 PMTake a look at Analysts Tips: Astrazeneca PLC (NYSE:AZN) , Express Scripts Holding Company (NASDAQ:ESRX) - Street Updates
07/28/16 08:38 AMExpress Scripts Announces Final Results of Maximum Tender Offers - [at noodls] - ST. LOUIS, Mo., July 28, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the 'Company' or 'Express Scripts') today announced the final tender results for its previously announced tender ...
07/28/16 06:38 AMWorthy Stock Update: Express Scripts Holding Company (NASDAQ:ESRX) - News Oracle
07/27/16 04:03 PMExpress Scripts (ESRX) Posts In-Line Earnings, Lags Revenues (Revised)
07/27/16 04:03 PMMattel Becomes #5 Most Shorted Nasdaq 100 Component, Replacing Express Scripts Holding
07/26/16 10:03 PMExpress Scripts (ESRX) Tops Q2 Earnings, Lags Revenues
07/26/16 10:03 PMExpress Scripts Holding (ESRX) Timothy C. Wentworth on Q2 2016 Results - Earnings Call Transcript
07/26/16 03:56 PMCan Express Scripts Holding Company (NASDAQ:ESRX) Surprise Analysts this Quarter? - Investor Newswire
07/26/16 03:56 PM3 Stocks to Watch on Tuesday: Express Scripts Holding Company (ESRX), Las Vegas Sands Corp. (LVS) and Gilead ... - Investorplace.com
07/25/16 09:23 PMExpress Scripts Raises Mid-Point Of 2016 Adjusted EPS Guidance - Quick Facts
07/25/16 03:54 PMEarnings Whispers: Gilead Sciences, Inc. (NASDAQ:GILD) & Express Scripts Holding Company (NASDAQ:ESRX) - TCC
07/25/16 03:28 PMExpress Scripts Announces 2016 Second Quarter Results; Narrows 2016 Full-Year Adjusted Diluted EPS Guidance Range; Raises Mid-Point; Provides 2016 Third Quarter Guidance - [at noodls] - ST. LOUIS, July 25, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 second quarter net income of $720.7 million, or $1.13 per diluted share. 2016 second quarter adjusted ...
07/25/16 03:19 PMExpress Scripts (ESRX) Stock Up in After-Hours Trading, Reports In-Line Q2 Results -
07/25/16 03:11 PMExpress Scripts shares fall after company misses revenue expectations -
07/25/16 03:11 PMExpress Scripts meets 2Q profit forecasts -
07/25/16 08:33 AMHC Stocks Analysis: Express Scripts Holding Company (NASDAQ:ESRX) Puma Biotechnology Inc (NYSE:PBYI) - share market updates (press release)
07/25/16 08:18 AMWhat to Watch When Express Scripts Holding Company Reports Earnings -
07/25/16 06:07 AMQ2 2016 Express Scripts Holding Co Earnings Release - After Market Close -
07/22/16 06:01 AMExpress Scripts Holding Company (NASDAQ:ESRX): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/22/16 06:01 AMEquity Roundup: Stock Performance Focus on Express Scripts Holding Company (NASDAQ:ESRX) - Press Telegraph
07/22/16 06:01 AMStock Session in the Rear-View for Express Scripts Holding Company (NASDAQ:ESRX) - TGP
07/22/16 06:01 AMExpress Scripts (ESRX) Q2 Earnings: Stock to Disappoint? - Nasdaq
07/22/16 06:01 AMHC Stocks News Bulletin: Express Scripts Holding Company (NASDAQ:ESRX), Celgene Corporation (NASDAQ:CELG) - share market updates (press release)
07/21/16 04:02 PMSouth Africa to appeal Pistorius six-year murder sentence: Radio 702
07/21/16 04:02 PMKelman-lazarov buys $4530764 stake in Express Scripts Holding Company (ESRX)
07/21/16 08:23 AMExpress Scripts (ESRX) Q2 Earnings: Stock to Disappoint? -
07/20/16 05:10 PMExpress Scripts Holding Company (NASDAQ:ESRX) Current Analyst Ratings - Fiscal Standard
07/20/16 06:13 AMProfessional Advisory Services Inc Lowers stake in Express Scripts Holding Company (ESRX) - TheFounders Daily
07/19/16 09:08 PMShares Lower on the Year Express Scripts Holding Company (NASDAQ:ESRX) - Press Telegraph
07/19/16 09:08 PMStocks Under Review: Express Scripts Holding Company (ESRX) Juno Therapeutics Inc. (JUNO) General Growth ... - iStreetWire
07/19/16 09:08 PMHC Stocks Alerts: Express Scripts Holding Company (NASDAQ:ESRX) Aetna Inc (NYSE:AET) - share market updates (press release)
07/19/16 09:08 PMNotable Analyst's Ranking Preview: Valeant Pharmaceuticals International, Inc. (NYSE:VRX) , Express Scripts Holding ... - Street Updates
07/19/16 09:08 PMExpress Scripts Holding Company Realized Volatility Hits Extremely Low Level - CML News
07/19/16 09:08 PMStock Strength in Focus for Express Scripts Holding Company (NASDAQ:ESRX) - Press Telegraph
07/19/16 08:30 AMZacks.com featured highlights: Williams-Sonoma, Washington Federal, Express Scripts Holding, Citrix Systems and Monarch Casino & Resort -
07/18/16 07:51 AM6 GARP Stocks Poised to Yield Healthy Returns -
07/17/16 03:34 PMExpress Scripts Holding Company (NASDAQ:ESRX) Check on Sentiment Score - Press Telegraph
07/17/16 08:24 AMShare Performance Summary for: Express Scripts Holding Company (NASDAQ:ESRX) - Press Telegraph
07/15/16 02:54 PMExpress Scripts : Clearent Appoints New Chief Financial Officer
07/14/16 09:14 PMExpress Scripts Holding Company (NASDAQ:ESRX): Stock Review and Performance Update - Press Telegraph
07/14/16 09:14 PMTrading Performance and Target Watch for Express Scripts Holding Company (NASDAQ:ESRX) - Press Telegraph
07/14/16 09:14 PMEye Catching Stock for investors: Express Scripts Holding Company (NASDAQ:ESRX) - News Oracle
07/01/16 08:00 PMINVESTOR NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit Against Express Scripts Holding Company and Encourages Investors With Losses to Contact the Firm - [Business Wire] - Goldberg Law PC announces that a class action lawsuit has been filed against Express Scripts Holding Company .
07/01/16 08:50 AMUPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors in Express Scripts Holding Company of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 5, 2016 - ESRX - [PR Newswire] - NEW YORK, July 1, 2016 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Express Scripts Holding ...
06/30/16 12:17 PMJuly 5 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against Express Scripts Holding Company - [Business Wire] - Law Offices of Howard G. Smith reminds investors of the upcoming July 5, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class of investors who purchased Express Scripts Holding Company securities between February 24, 2015 and March 21, 2016, inclusive .
06/30/16 09:07 AMDEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action against Express Scripts Holding Company (ESRX) and Lead Plaintiff Deadline July 5, 2016 - [Accesswire] - NEW YORK, NY / ACCESSWIRE / June 30, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court, Southern District of ...

Social

About Express Scripts Holding

Express Scripts Holding logoExpress Scripts, Inc. is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM). PBM segment’s services include retail network pharmacy management and retail drug card programs, home delivery services, specialty benefit services, patient care contact centers, benefit plan design and consultation, drug formulary management, compliance and therapy management programs, information reporting and analysis programs, rebate programs, and electronic claims processing and drug utilization review. EM segment’s services include distribution of pharmaceuticals and medical supplies to providers and clinics and healthcare account administration and implementation of consumer-directed healthcare solutions.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Health Care Plans
  • Sub-Industry: Health Care Services
  • Exchange: NASDAQ
  • Symbol: ESRX
  • CUSIP: 30219G10
Key Metrics:
  • Previous Close: $76.07
  • 50 Day Moving Average: $76.69
  • 200 Day Moving Average: $72.88
  • P/E Ratio: 18.80
  • P/E Growth: 0.79
  • Market Cap: $47.94B
  • Beta: 1.35
  • Current Year EPS Consensus Estimate: $6.37 EPS
  • Next Year EPS Consensus Estimate: $6.88 EPS
Additional Links:
Express Scripts Holding (NASDAQ:ESRX) Chart for Saturday, July, 30, 2016